Source: 4-traders

PMC Biogenix: PMC Biogenix Announces Price Increase on Certain Product Lines

(4-traders.com) PMC Biogenix Inc. announces that effective January 1, 2018 or as contracts permit, prices for products sold under the trademarks Armoslip®, Hystrene®, Industrene®, Kemamide®, Kemester®, and Lubrazinc® will increase by 3% (three percent). Customers with questions should...http://www.4-traders.com/news/PMC-Biogenix-Announces-Price-Increase-on-Certain-Product-Lines--25624785/?utm_medium=RSS&utm_content=20171206

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more